CannabisNewsBreaks

WednesdaySep 29, 2021 12:57 pm

CannabisNewsBreaks – The Alkaline Water Company Inc.’s (NASDAQ: WTER) (CSE: WTER) Alkaline88(R) Now Ranks as Country’s 8th Largest Enhanced Water

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today shared highlights from the most recent Nielsen data for the 52-week and four-week periods ending Sept. 11, 2021. According to the four-week data, Alkaline88(R) is now the 8th largest enhanced water in the country in the all-important grocery channel. The company’s unit growth in grocery outpaces the entire category by 12.6 times over the last year and 32 times over the past four weeks. “The Alkaline Water Company continues to grow and gain market share in the value-added water…

Continue Reading

WednesdaySep 29, 2021 11:30 am

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Enters Strategic Partnership, Consulting Contract with Lelantos Holdings Inc.

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, today announced that it has executed a partnership and consulting contract with Lelantos Holdings Inc. The collaboration is intended to assist the company in becoming publicly traded while also providing business advisory services for an array of strategic projects. Lelantos Holdings, a corporate advisory company that seeks to acquire, purchase and/or joint venture with established entities in strategic and emerging market sectors, is managed and operated by the founders of Sonder Fulfillment LLC, a wholly owned subsidiary of Golden Triangle Ventures. “We…

Continue Reading

TuesdaySep 28, 2021 1:25 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Initiates Pilot Program with Four 20 Pharma in Germany

RYAH Group (CSE: RYAH) today announced that it has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers for use in a pilot study to be conducted by Four 20 Pharma GmbH, a leading manufacturer, wholesaler and importer of medical cannabis and medical devices. The study is being conducted in preparation for a wider distribution strategy for the RYAH Smart Dry Herb Inhaler and data analytics platform in the German market. Four 20 is expected to sponsor the launch of an observational study using the RYAH inhalers in order to collect accurate patient feedback on consumption of…

Continue Reading

MondaySep 27, 2021 1:45 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Launches Keef Beverages in Ontario Through the OCS

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced the shipment of its award-winning Keef Brands cannabis-infused beverages to the Ontario Cannabis Store (“OCS”). According to the update, the Keef products will be available in Ontario retail locations across the province and online at OCS.ca in October 2021. The products are also expected to hit British Columbia and Alberta shelves by early November 2021. “We’re very excited to launch these top-selling and highly anticipated beverages in Ontario through the OCS,” said BevCanna’s President Melise Panetta. “The OCS is the largest…

Continue Reading

MondaySep 27, 2021 1:11 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn process into larger vessels,” Adams said in a recent…

Continue Reading

MondaySep 27, 2021 12:55 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

Continue Reading

MondaySep 27, 2021 11:49 am

CannabisNewsBreaks – Hero Technologies (HENC) Announces Subsidiary Receive Key Approval for Cannabis Licenses

Hero Technologies (OTC: HENC), a cannabis company, and its subsidiary BlackBox Systems and Technologies LLC, has received step 1 prequalification approval for a class C adult-use cannabis license in the state of Michigan. The company also fulfilled the requirements for step 1 prequalification approval to receive a class C medicinal use cannabis license in Michigan. With these steps taken, the company now plans to start the process for step 2 establishment use or full license approval for a newly constructed medical marijuana facility. According to the announcement, once Hero Technologies completes step 2 with the Michigan Marijuana Regulatory Agency (“MRA”), it…

Continue Reading

FridaySep 24, 2021 2:11 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article. In addition to the antiviral program, Lexaria is also focused on another applied R&D program — hypertension. On July 29, it released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for…

Continue Reading

FridaySep 24, 2021 1:56 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a pioneer in cannabis and hemp-derived product lines, strategically positioning itself to be among the top three multistate operators of these products within the American market. In late July of this year, the company released its Q1 2021 financial results in what Brand Rogers, RWB Chairman and CEO, described as “another great quarter for the company.” A recent article reads, “When making the announcement, Mr. Rogers also noted that the company would be building on the momentum from Q1, given how much traction it had received for its brand. More…

Continue Reading

FridaySep 24, 2021 1:06 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Release FY 2021 Financial Report and Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has released its financial results and corporate update for FY 2021. In addition, the company announced a conference call and webcast, in which company leadership will discuss the report. Interested parties can access a replay of the webcast for 90 days. Corporate highlights of the report include the definitive agreement the company entered to acquire BayMedica Inc., a private company specializing in the manufacture and commercialization of rare cannabinoids; the announcement that INM’s IntegraSyn(TM) cannabinoid manufacturing approach had achieved a level of 2g/L cannabinoid yield,…

Continue Reading